NIH-OWNED CHIMPANZEE RESEARCH RESOURCE AT THE SNPRC
NIH-OWNED CHIMPANZEE RESEARCH RESOURCE AT THE SNPRC
批准号:
8356917
负责人:
JOHN L VANDEBERG
金额:
$47.12万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-05 至 2012-07-31
关键词:
BiochemicalBiomedical ResearchCaringCharacteristicsCognitionCommunitiesDataDatabasesExperimental DesignsFundingGene Expression ProfileGeneticGenomicsGrantHIVHealthHealth StatusHepatitisHepatitis B VirusHepatitis C virusHumanHuman immunodeficiency virus testIndividualInfectionLiverMeasuresMessenger RNAMicroRNAsModelingNational Center for Research ResourcesPan GenusPeripheral Blood Mononuclear CellPharmaceutical PreparationsPhysiologicalPhysiologyPlayPopulationPreventionPrincipal InvestigatorRelative (related person)ResearchResearch InfrastructureResearch PersonnelResourcesRoleSamplingSourceTimeUnited States National Institutes of Healthcohortcostdesigngenome sequencinghumanized monoclonal antibodiesinfectious disease treatmentmannovel therapeutic interventionprogramspublic educationpublic health relevancesafety testing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
DESCRIPTION (provided by applicant): The genetic, physiological, biochemical, and immunological similarities of chimpanzees to humans make them unique models for biomedical research directed at many aspects of human health including, among others, developing preventions and treatments for infectious diseases (e.g., HBV, HCV, HIV), testing the effects of drugs specifically designed for use in humans, and testing the safety and efficacy of humanized monoclonal antibodies. The overall objective of this project is to maintain an NCRR-owned research resource consisting of 209 chimpanzees and to manage it to serve the national biomedical research needs. We will pursue the following specific aims: 1) To maintain a stable, healthy, well defined population of chimpanzees and to make them available for research; 2) To maintain a cohort of well characterized chimpanzees persistently infected with HBV, HCV or HIV for research on hepatitis and AIDS and for testing the efficacy of new therapeutic approaches; 3) To develop a unique resource of fully sequenced transcriptomes from liver samples of all 209 chimpanzees, including mRNAs and microRNAs, and from PBMC samples of a subset of 36 chimpanzees that are chronically infected with HCV or that have cleared the infection; 4) To develop longitudinal quantitative measures of physiological characteristics that are of importance to biomedical research and to analyze them in relation to sequence data from Aim 3 and in relation to health status; 5) To develop a data base that contains information about the chimpanzees and the data obtained under Aims 3 and 4, and to make it available to the national biomedical research community for research purposes and for selection of experimental subjects; 6) To establish a program for educating the public as to the importance of chimpanzees in biomedical research. Via fulfilling these aims, we will establish a chimpanzee resource that is unique among all chimpanzee research resources in enabling investigators for the first time to exploit genome sequence data from individual chimpanzees in experimental design and in genomic analyses. In addition, the educational program will contribute to the public's understanding of the care and use of chimpanzees in biomedical research, and the need for resources such as the one proposed in this application.
PUBLIC HEALTH RELEVANCE (provided by applicant): Chimpanzees are man's closest relative and play a unique role in research aimed at understanding human physiology and cognition. The proposed project will complete the establishment of a research resource involving 209 chimpanzees owned by NIH. These chimpanzees, and data derived from them, will be made available to the biomedical research community, and a public education program about the importance of chimpanzees in biomedical research will be established.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Creation of Knockout Laboratory Opossums
-
批准号:10648854
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2023
-
负责人:JOHN L VANDEBERG
-
依托单位:
Creation of Knockout Laboratory Opossums
-
批准号:10878570
-
项目类别:
-
资助金额:$2.9万
-
财政年份:2023
-
负责人:JOHN L VANDEBERG
-
依托单位:
NIH-Owned Chimpanzee Research Resource at the SNPRC
-
批准号:8500875
-
项目类别:
-
资助金额:$14.29万
-
财政年份:2011
-
负责人:JOHN L VANDEBERG
-
依托单位:
NIH-Owned Chimpanzee Research Resource at the SNPRC
-
批准号:8199796
-
项目类别:
-
资助金额:$47.12万
-
财政年份:2011
-
负责人:JOHN L VANDEBERG
-
依托单位:
NIH-Owned Chimpanzee Research Resource at the SNPRC
-
批准号:8328712
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2011
-
负责人:JOHN L VANDEBERG
-
依托单位:
RHESUS BREEDING COLONY IN NEPAL AND IMPORTATION TO USA
-
批准号:8357648
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2011
-
负责人:JOHN L VANDEBERG
-
依托单位:
TB VACCINE DEVELOPMENT IN NONHUMAN PRIMATE MODEL
-
批准号:8357662
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2011
-
负责人:JOHN L VANDEBERG
-
依托单位:
DIET AND GENOTYPE IN PRIMATE ATHEROSCLEROSIS: ADMINISTRATION
-
批准号:8357666
-
项目类别:
-
资助金额:$16.7万
-
财政年份:2011
-
负责人:JOHN L VANDEBERG
-
依托单位:
CHAGAS DISEASE: AN EMERGING FATAL DISEASE IN TEXAS
-
批准号:8357671
-
项目类别:
-
资助金额:$2.71万
-
财政年份:2011
-
负责人:JOHN L VANDEBERG
-
依托单位:
NIH-Owned Chimpanzee Research Resource at the SNPRC
-
批准号:8543216
-
项目类别:
-
资助金额:$268.19万
-
财政年份:2011
-
负责人:JOHN L VANDEBERG
-
依托单位:
THERAPY FOR CHAGAS DISEASE IN BABOON MODEL
-
批准号:8357695
-
项目类别:
-
资助金额:$7.87万
-
财政年份:2011
-
负责人:JOHN L VANDEBERG
-
依托单位:
DIET AND GENOTYPE IN PRIMATE ATHEROSCLEROSIS: ADMINISTRATION
-
批准号:8172676
-
项目类别:
-
资助金额:$4.05万
-
财政年份:2010
-
负责人:JOHN L VANDEBERG
-
依托单位:
RHESUS BREEDING COLONY IN NEPAL AND IMPORTATION TO USA
-
批准号:8172649
-
项目类别:
-
资助金额:$46.48万
-
财政年份:2010
-
负责人:JOHN L VANDEBERG
-
依托单位:
TB VACCINE DEVELOPMENT IN NONHUMAN PRIMATE MODEL
-
批准号:8172672
-
项目类别:
-
资助金额:$27.4万
-
财政年份:2010
-
负责人:JOHN L VANDEBERG
-
依托单位:
ADMINISTRATION
-
批准号:8147449
-
项目类别:
-
资助金额:$48.21万
-
财政年份:2010
-
负责人:JOHN L VANDEBERG
-
依托单位:
GENETICS OF ARTERIAL AND PROGENITOR ENDOTHELIAL CELLS
-
批准号:8147435
-
项目类别:
-
资助金额:$48.21万
-
财政年份:2010
-
负责人:JOHN L VANDEBERG
-
依托单位:
CHAGAS DISEASE: AN EMERGING FATAL DISEASE IN TEXAS
-
批准号:8172687
-
项目类别:
-
资助金额:$17.8万
-
财政年份:2010
-
负责人:JOHN L VANDEBERG
-
依托单位:
Improvement of Nonhuman Primate Group Housing
-
批准号:7856338
-
项目类别:
-
资助金额:$46.68万
-
财政年份:2010
-
负责人:JOHN L VANDEBERG
-
依托单位:
GENETICS OF ARTERIAL AND PROGENITOR ENDOTHELIAL CELLS
-
批准号:8172707
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2010
-
负责人:JOHN L VANDEBERG
-
依托单位:
THERAPY FOR CHAGAS DISEASE IN BABOON MODEL
-
批准号:8172726
-
项目类别:
-
资助金额:$13.43万
-
财政年份:2010
-
负责人:JOHN L VANDEBERG
-
依托单位:
海外基金